Origin Investment Corp I cures Nasdaq audit committee composition deficiency
Origin Investment Corp I received notice on July 15, 2026 from Nasdaq that it had failed to comply with audit committee composition requirements under Nasdaq Listing Rule 5605(c)(2) by the July 2, 2026 deadline of its one-year phase-in period from the company's July 1, 2025 IPO registration date. On July 13, 2026, before the deficiency notice was issued, the company appointed director Daniel Alef as an independent audit committee member, satisfying the rule's requirement for three independent members. Nasdaq Staff subsequently determined the company achieved compliance and closed the matter.
Key facts
- Nasdaq phase-in period ended July 2, 2026; company had failed to appoint required third independent audit committee member
- Daniel Alef appointed to Audit Committee on July 13, 2026
- Board determined Alef qualifies as independent director under Nasdaq Listing Rule 5605(a)(2) and meets enhanced audit committee independence requirements
- One-year phase-in period granted from July 1, 2025, the effective date of the company's Form S-1 registration statement
- Nasdaq Staff determined company complies with Nasdaq Listing Rule 5605(c)(2) after Alef appointment
Why it matters
The company avoided a delisting determination by curing the deficiency before Nasdaq took adverse action; the appointment restored full compliance with Nasdaq's corporate governance composition standard.
Share
Derived from 8-K filed 2026-07-21. Not investment advice. View the source filing on SEC.gov →